PubRank

HbA1c Variability in Type II Diabetes

Clinical Trial ID NCT02879409

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02879409

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993 102.56
2 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 95.79
3 Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 47.90
4 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 38.76
5 Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000 35.06
6 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 34.34
7 Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998 32.73
8 Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2008 25.70
9 Analysis of serial measurements in medical research. BMJ 1990 16.69
10 Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008 8.82
11 Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 2004 8.06
12 The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006 6.83
13 Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002 6.61
14 Testing for baseline balance in clinical trials. Stat Med 1994 3.01
15 Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care 2009 2.50
16 Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]. Kidney Int 1993 1.90
17 A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes 2009 1.55
18 Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009 1.52
19 Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes. Diabetologia 2007 1.46
20 Hypothesis: the 'metabolic memory', the new challenge of diabetes. Diabet Med 2007 1.43
21 HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2. Diabetologia 2012 1.41
22 Development of a semi-quantitative food frequency questionnaire for use in United Arab Emirates and Kuwait based on local foods. Nutr J 2005 1.33
23 Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia 2009 1.30
24 Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes. Curr Med Res Opin 2005 1.12
25 Better glycaemic control and risk reduction of diabetic complications in Type 2 diabetes: comparison with the DCCT. Diabetes Res Clin Pract 1998 1.07
26 Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial. Diabetes Care 2014 1.07
27 The biological variation of sex hormone-binding globulin in type 2 diabetes: implications for sex hormone-binding globulin as a surrogate marker of insulin resistance. Diabetes Care 2004 0.90
28 Corneal confocal microscopy shows an improvement in small-fiber neuropathy in subjects with type 1 diabetes on continuous subcutaneous insulin infusion compared with multiple daily injection. Diabetes Care 2015 0.85
29 Status and rationale of renoprotection studies in adolescents with type 1 diabetes. Pediatr Diabetes 2009 0.83
Next 100